Chloropicrin From China, 21346 [2010-9403]

Download as PDF 21346 Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Notices Oregon Resource Advisory Council (SEORAC) will meet as indicated below: DATES: The meeting will begin at 7 p.m. (Pacific Daylight Time) on May 6, 2010. ADDRESSES: The SEORAC will meet by teleconference. For a copy of material to be discussed or the conference call number, please contact the BLM Vale District; information below. FOR FURTHER INFORMATION CONTACT: Mark Wilkening, Public Affairs Officer, BLM Vale District Office, 100 Oregon Street, Vale, Oregon 97918, or by telephone at (541) 473–6218. SUPPLEMENTARY INFORMATION: The SEORAC will conduct a public meeting by teleconference to discuss and come to consensus on contents of a letter to be sent to the Oregon/Washington BLM State Director on the Final Environmental Impact Statement for Vegetation Treatments Using Herbicides on BLM Lands in Oregon. The conference call meeting is open for the public to access by telephone. Public comment is scheduled from 7:45 to 8 p.m. (Pacific Daylight Time) May 6, 2010. For a copy of the information distributed to the SEORAC members please contact Mark Wilkening, Public Affairs Officer, BLM Vale District Office, 100 Oregon Street, Vale, Oregon 97918, or by telephone at (541) 473–6218. Larry Frazier, Acting District Manager, Vale District Office. [FR Doc. 2010–9430 Filed 4–22–10; 8:45 am] BILLING CODE 4310–33–P and determined on October 15, 2009 that it would conduct a full review (74 FR 55065, October 26, 2009). Notice of the scheduling of the Commission’s review and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on October 15, 2009 (74 FR 55065). Counsel for the three domestic producers of chloropicrin offered to submit written testimony in lieu of an oral hearing presentation. In connection with the offer of written testimony, counsel indicated a willingness to respond to written questions of the Commissioners by a date to be set by the Commission. No other party filed a request to appear at the hearing. Consequently, the public hearing in connection with the review, scheduled to begin at 9:30 a.m. on February 18, 2010, at the U.S. International Trade Commission Building was cancelled. The Commission transmitted its determination in this investigation to the Secretary of Commerce on April 19, 2010. The views of the Commission are contained in USITC Publication 4142 (April 2010), entitled Chloropicrin from China: Investigation No. 731–TA–130 (Third Review). By order of the Commission. Issued: April 19, 2010. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. 2010–9403 Filed 4–22–10; 8:45 am] INTERNATIONAL TRADE COMMISSION BILLING CODE 7020–02–P [Investigation No. 731–TA–130 (Third Review)] INTERNATIONAL TRADE COMMISSION Chloropicrin From China [Investigation Nos. 701–TA–468 and 731– TA–1166–1167 (Final)] WReier-Aviles on DSKGBLS3C1PROD with NOTICES Determination On the basis of the record 1 developed in the subject five-year review, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), that revocation of the antidumping duty order on chloropicrin from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted this review on July 1, 2009 (74 FR 31760) 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). VerDate Nov<24>2008 15:23 Apr 22, 2010 Jkt 220001 Certain Magnesia Carbon Bricks From China and Mexico AGENCY: United States International Trade Commission. ACTION: Scheduling of the final phase of a countervailing duty investigation and antidumping investigations. SUMMARY: The Commission hereby gives notice of the scheduling of the final phase of a countervailing duty investigation No. 701–TA–468 (Final) and antidumping investigation Nos. 731–TA–1166–1167 (Final) under sections 705(b) and 735(b) of the Tariff Act of 1930 (19 U.S.C. 1671d(b) and 1673d(b)) (the Act) to determine whether an industry in the United States is materially injured or PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of subsidized imports from China or less-than-fair-value imports from China or Mexico of certain magnesia carbon bricks, provided for in subheadings 6902.10.10, 6902.10.50, 6815.91.00, and 6815.99.00 of the Harmonized Tariff Schedule of the United States.1 For further information concerning the conduct of this phase of the investigations, hearing procedures, and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subparts A and C (19 CFR part 207). DATES: Effective Date: March 12, 2010. FOR FURTHER INFORMATION CONTACT: Elizabeth Haines (202–205–3200), Office of Investigations, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436. Hearingimpaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Background.—The final phase of these investigations is being scheduled as a result of a negative preliminary determination by the Department of Commerce that certain benefits which constitute subsidies within the meaning of section 703 of the Act (19 U.S.C. 1671b) are being provided to manufacturers, producers, or exporters in China of certain magnesia carbon bricks, and affirmative preliminary determinations that imports of certain 1 For purposes of these investigations, the Department of Commerce has defined the subject merchandise as ‘‘certain chemically bonded (resin or pitch), magnesia carbon bricks with a magnesia component of at least 70 percent magnesia (‘‘MgO’’) by weight, regardless of the source of raw materials for the MgO, with carbon levels ranging from trace amounts to 30 percent by weight, regardless of enhancements, (for example, magnesia carbon bricks can be enhanced with coating, grinding, tar impregnation or coking, high temperature heat treatments, anti-slip treatments or metal casing) and regardless of whether or not antioxidants are present (for example, antioxidants can be added to the mix from trace amounts to 15 percent by weight as various metals, metal alloys, and metal carbides).’’ E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Page 21346]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9403]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-130 (Third Review)]


Chloropicrin From China

Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission (Commission) 
determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 
U.S.C. 1675(c)), that revocation of the antidumping duty order on 
chloropicrin from China would be likely to lead to continuation or 
recurrence of material injury to an industry in the United States 
within a reasonably foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted this review on July 1, 2009 (74 FR 31760) 
and determined on October 15, 2009 that it would conduct a full review 
(74 FR 55065, October 26, 2009). Notice of the scheduling of the 
Commission's review and of a public hearing to be held in connection 
therewith was given by posting copies of the notice in the Office of 
the Secretary, U.S. International Trade Commission, Washington, DC, and 
by publishing the notice in the Federal Register on October 15, 2009 
(74 FR 55065). Counsel for the three domestic producers of chloropicrin 
offered to submit written testimony in lieu of an oral hearing 
presentation. In connection with the offer of written testimony, 
counsel indicated a willingness to respond to written questions of the 
Commissioners by a date to be set by the Commission. No other party 
filed a request to appear at the hearing. Consequently, the public 
hearing in connection with the review, scheduled to begin at 9:30 a.m. 
on February 18, 2010, at the U.S. International Trade Commission 
Building was cancelled.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on April 19, 2010. The views of the 
Commission are contained in USITC Publication 4142 (April 2010), 
entitled Chloropicrin from China: Investigation No. 731-TA-130 (Third 
Review).

    By order of the Commission.

     Issued: April 19, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 2010-9403 Filed 4-22-10; 8:45 am]
BILLING CODE 7020-02-P